MCOV-B 📈 Medicover AB (publ) - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0009778848
MCOV-B: Healthcare services, Diagnostic services, Medical tests
Medicover AB (publ) operates as a comprehensive healthcare provider, offering a broad range of services across Poland, Sweden, and international markets. The company's healthcare services segment encompasses a diverse portfolio, including outpatient and inpatient care, dental services, and other non-medical related services such as sports memberships, benefit cards, and optics, in addition to wellness services. Furthermore, hospital care and preventive care are also integral components of their healthcare offerings, underscoring the company's commitment to delivering holistic care solutions. This multifaceted approach enables Medicover to cater to a wide range of needs, from routine check-ups to complex medical procedures.
The diagnostic services arm of Medicover AB (publ) is equally robust, featuring an extensive array of tests designed to facilitate accurate diagnoses and informed treatment decisions. These tests span various disciplines, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry, and immunochemistry, among others. The company's diagnostic capabilities also extend to blood group diagnostics, transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. This breadth of diagnostic services positions Medicover as a one-stop solution for patients and healthcare providers seeking comprehensive diagnostic support.
Medicover AB (publ) serves a diverse client base, comprising corporate entities, individuals, and public payers. This diversified approach allows the company to leverage its expertise and resources across different markets and customer segments, fostering growth and stability. Founded in 1995, Medicover has established a strong presence in the healthcare industry, with its headquarters located in Stockholm, Sweden. The company's web presence can be accessed at https://www.medicover.com, providing a gateway to its services, mission, and values. With its common stock listed under the ISIN SE0009778848 and classified under the GICS Sub Industry: Health Care Services, Medicover AB (publ) is poised for continued expansion and innovation in the healthcare sector.
Additional Sources for MCOV-B Stock
MCOV-B Stock Overview
Market Cap in USD | 2,424m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception |
MCOV-B Stock Ratings
Growth 5y | 37.6% |
Fundamental | 16.3% |
Dividend | 49.1% |
Rel. Strength Industry | 1247 |
Analysts | - |
Fair Price Momentum | 182.69 SEK |
Fair Price DCF | 43.11 SEK |
MCOV-B Dividends
Dividend Yield 12m | 0.06% |
Yield on Cost 5y | 0.11% |
Annual Growth 5y | 19.68% |
Payout Consistency | 98.8% |
MCOV-B Growth Ratios
Growth Correlation 3m | -29.9% |
Growth Correlation 12m | 48.7% |
Growth Correlation 5y | 26.5% |
CAGR 5y | 12.58% |
CAGR/Mean DD 5y | 0.35 |
Sharpe Ratio 12m | 0.73 |
Alpha | 5.76 |
Beta | 0.89 |
Volatility | 44.25% |
Current Volume | 48.1k |
Average Volume 20d | 42.5k |
As of December 21, 2024, the stock is trading at SEK 192.40 with a total of 48,147 shares traded.
Over the past week, the price has changed by +2.36%, over one month by +10.14%, over three months by -1.95% and over the past year by +31.42%.
Neither. Based on ValueRay Fundamental Analyses, Medicover AB (publ) is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCOV-B as of December 2024 is 182.69. This means that MCOV-B is currently overvalued and has a potential downside of -5.05%.
Medicover AB (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, MCOV-B Medicover AB (publ) will be worth about 202.2 in December 2025. The stock is currently trading at 192.40. This means that the stock has a potential upside of +5.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 223.5 | 16.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 202.2 | 5.1% |